--- type: Conversation title: grant questions - fbi inquiry - 1-r01ai110964-01 - 2-r01ai110964-06 description: "email conversation, 140 messages, 2020-05-13." tags: - conversation - email medium: email message_count: 140 started_at: "2020-05-13T11:59:00" ended_at: "2020-09-14T16:42:00" duration_seconds: 10730580 sources: - { id: reading_room, resource: /sources/reading-room.md, title: Reading Room Production, author: "process:senate-hsgac-release" } generated: { by: randpaul-corpus-pipeline/1.0, at: "2026-08-01T12:42:27Z" } status: stable --- A email conversation of 140 messages spanning 2980h 43m. # Metadata - **Started:** 2020-05-13T11:59:00 - **Ended:** 2020-09-14T16:42:00 - **Duration:** 2980h 43m - **Participants:** 22 - **Source:** [reading_room](/sources/reading-room.md) - **Pages:** 2-281 # Participants * [Ashley Sanders](/people/ashley-sanders.md) * Black * Black * Black * Black * Black * Black * Black * Black * Black * Black * Black * Black * Black * Black * Black * Black * Bulls * Bulls * Bulls * Bulls * Bulls * Bulls * Bulls * Bulls * Bulls * Bulls * Bulls * Bulls * [David A Miller](/people/david-a-miller.md) * [Deborah Kearse](/people/deborah-kearse.md) * [Diane Dean](/people/diane-dean.md) * Emily * Emily * [Emily Linde](/people/emily-linde.md) * Erik * Erik * Erik * Erik * Erik * Erik * [Erik Stemmy](/people/erik-stemmy.md) * Jodi * Jodi * Jodi * Jodi * Jodi * Jodi * Jodi * Jodi * Jodi * Jodi * Jodi * Jodi * Jodi * Jodi * Jodi * Jodi * [Jodi Black](/people/jodi-black.md) * Lauer * Lauer * Lauer * Lauer * Linde * Linde * Michael * Michael * Michael * Michael * [Michael Lauer](/people/michael-lauer.md) * [Michelle G](/people/michelle-g.md) * [Michelle G Bulls](/people/michelle-g-bulls.md) * Mike * Mike * Mike * Mike * [Mike Shannon](/people/mike-shannon.md) * Shannon * Shannon * Shannon * Shannon # Transcript **[2020-05-13T11:59:00] Ashley Sanders:** Good afternoon Emily, OMA/DPI received questions related to an FBI inquiry for the following NIAID grants: 1R01AI110964-01 through 2R01AI110964-06. The agent is requesting clarification on the details of the study, where certain aspects were performed, and whether seamless cloning techniques were used. I note you were the last official to sign off on 4/27/20. Would you be able to provide a response to the below-captured questions and/or be available for a joint call with our office and the agent? If not, who would be the best SME on this matter? I'm sure you understand, since this is a sensitive matter, we need to maintain confidentiality and limit the touch-points within NIH. I'm happy to… **[2020-05-13T11:59:00] Ashley Sanders:** Good afternoon Emily, OMA/DPI received questions related to an FBI inquiry for the following NIAID grants: 1R01AI110964-01 through 2R01AI110964-06. The agent is requesting clarification on the details of the study, where certain aspects were performed, and whether seamless cloning techniques were used. I note you were the last official to sign off on 4/27/20. Would you be able to provide a response to the below-captured questions and/or be available for a joint call with our office and the agent? If not, who would be the best SME on this matter? I'm sure you understand, since this is a sensitive matter, we need to maintain confidentiality and limit the touch-points within NIH. I'm happy to… **[2020-05-13T11:59:00] Ashley Sanders:** Good afternoon Emily, OMA/DPI received questions related to an FBI inquiry for the following NIAID grants: 1R01AI110964-01 through 2R01AI110964-06. The agent is requesting clarification on the details of the study, where certain aspects were performed, and whether seamless cloning techniques were used. I note you were the last official to sign off on 4/27/20. Would you be able to provide a response to the below-captured questions and/or be available for a joint call with our office and the agent? If not, who would be the best SME on this matter? I'm sure you understand, since this is a sensitive matter, we need to maintain confidentiality and limit the touch-points within NIH. I'm happy to… **[2020-05-13T11:59:00] Ashley Sanders:** Good afternoon Emily, OMA/DPI received questions related to an FBI inquiry for the following NIAID grants: 1R01AI110964-01 through 2R01AI110964-06. The agent is requesting clarification on the details of the study, where certain aspects were performed, and whether seamless cloning techniques were used. I note you were the last official to sign off on 4/27/20. Would you be able to provide a response to the below-captured questions and/or be available for a joint call with our office and the agent? If not, who would be the best SME on this matter? I'm sure you understand, since this is a sensitive matter, we need to maintain confidentiality and limit the touch-points within NIH. I'm happy to… **[2020-05-13T11:59:00] Ashley Sanders:** 2rtain aspects were fficial to sign off on 4/27/20. you understand, since this is a sensitive I'm happy to discuss further if you have rt tes en at ing rt (Db ACE2 Expressing Mice with ction experiments as described Good afternoon Emily, OMA/DPI received questions related to an FBI inquiry for the following NIAID grants: 1R01AI110964-01 through 2R01AI110964-06. The agent is requesting clarification on the details of the study, where certain aspects were performed, and whether seamless cloning techniques were used. I note you were the last official to sign off on 4/27/20. Would you be able to provide a response to the below-captured questions and/or be available for a joint call with our… **[2020-05-13T11:59:00] Ashley Sanders:** Good afternoon Emily, OMA/DPI received questions related to an FBI inquiry for the following NIAID grants: 1R01AI110964-01 through 2R01AI110964-06. The agent is requesting clarification on the details of the study, where certain aspects were performed, and whether seamless cloning techniques were used. I note you were the last official to sign off on 4/27/20. Would you be able to provide a response to the below-captured questions and/or be available for a joint call with our office and the agent? If not, who would be the best SME on this matter? I'm sure you understand, since this is a sensitive matter, we need to maintain confidentiality and limit the touch-points within NIH. I'm happy to… **[2020-05-13T11:59:00] Ashley Sanders:** Good afternoon Emily, OMA/DPI received questions related to an FBI inquiry for the following NIAID grants: 1R01AI110964-01 through 2R01AI110964-06. The agent is requesting clarification on the details of the study, where certain aspects were performed, and whether seamless cloning techniques were used. I note you were the last official to sign off on 4/27/20. Would you be able to provide a response to the below-captured questions and/or be available for a joint call with our office and the agent? If not, who would be the best SME on this matter? I'm sure you understand, since this is a sensitive matter, we need to maintain confidentiality and limit the touch-points within NIH. I'm happy to… **[2020-05-13T11:59:00] Ashley Sanders:** Good afternoon Emily, OMA/DPI received questions related to an FBI inquiry for the following NIAID grants: 1R01AI110964-01 through 2R01AI110964-06. The agent is requesting clarification on the details of the study, where certain aspects were performed, and whether seamless cloning techniques were used. I note you were the last official to sign off on 4/27/20. Would you be able to provide a response to the below-captured questions and/or be available for a joint call with our office and the agent? If not, who would be the best SME on this matter? I'm sure you understand, since this is a sensitive matter, we need to maintain confidentiality and limit the touch-points within NIH. I'm happy to… **[2020-05-13T11:59:00] Ashley Sanders:** Good afternoon Emily, OMA/DPI received questions related to an FBI inquiry for the following NIAID grants: 1R01AI110964-01 through 2R01AI110964-06. The agent is requesting clarification on the details of the study, where certain aspects were performed, and whether seamless cloning techniques were used. I note you were the last official to sign off on 4/27/20. Would you be able to provide a response to the below-captured questions and/or be available for a joint call with our office and the agent? If not, who would be the best SME on this matter? I'm sure you understand, since this is a sensitive matter, we need to maintain confidentiality and limit the touch-points within NIH. I'm happy to… **[2020-05-13T11:59:00] Ashley Sanders:** Good afternoon Emily, OMA/DPI received questions related to an FBI inquiry for the following NIAID grants: 1R01AI110964-01 through 2R01AI110964-06. The agent is requesting clarification on the details of the study, where certain aspects were performed, and whether seamless cloning techniques were used. I note you were the last official to sign off on 4/27/20. Would you be able to provide a response to the below-captured questions and/or be available for a joint call with our office and the agent? If not, who would be the best SME on this matter? I'm sure you understand, since this is a sensitive matter, we need to maintain confidentiality and limit the touch-points within NIH. I'm happy to… **[2020-05-13T11:59:00] Ashley Sanders:** Good afternoon Emily, OMA/DPI received questions related to an FBI inquiry for the following NIAID grants: 1R01AI110964-01 through 2R01AI110964-06. The agent is requesting clarification on the details of the study, where certain aspects were performed, and whether seamless cloning techniques were used. I note you were the last official to sign off on 4/27/20. Would you be able to provide a response to the below-captured questions and/or be available for a joint call with our office and the agent? If not, who would be the best SME on this matter? I'm sure you understand, since this is a sensitive matter, we need to maintain confidentiality and limit the touch-points within NIH. I'm happy to… **[2020-05-13T11:59:00] Ashley Sanders:** 2rtain aspects were fficial to sign off on 4/27/20. you understand, since this is a sensitive I'm happy to discuss further if you have rt tes en at ing rt (Db ACE2 Expressing Mice with ction experiments as described Good afternoon Emily, OMA/DPI received questions related to an FBI inquiry for the following NIAID grants: 1R01AI110964-01 through 2R01AI110964-06. The agent is requesting clarification on the details of the study, where certain aspects were performed, and whether seamless cloning techniques were used. I note you were the last official to sign off on 4/27/20. Would you be able to provide a response to the below-captured questions and/or be available for a joint call with our… **[2020-05-13T11:59:00] Ashley Sanders:** Good afternoon Emily, OMA/DPI received questions related to an FBI inquiry for the following NIAID grants: 1R01AI110964-01 through 2R01AI110964-06. The agent is requesting clarification on the details of the study, where certain aspects were performed, and whether seamless cloning techniques were used. I note you were the last official to sign off on 4/27/20. Would you be able to provide a response to the below-captured questions and/or be available for a joint call with our office and the agent? If not, who would be the best SME on this matter? I'm sure you understand, since this is a sensitive matter, we need to maintain confidentiality and limit the touch-points within NIH. I'm happy to… **[2020-05-13T11:59:00] Ashley Sanders:** Good afternoon Emily, OMA/DPI received questions related to an FBI inquiry for the following NIAID grants: 1R01AI110964-01 through 2R01AI110964-06. The agent is requesting clarification on the details of the study, where certain aspects were performed, and whether seamless cloning techniques were used. I note you were the last official to sign off on 4/27/20. Would you be able to provide a response to the below-captured questions and/or be available for a joint call with our office and the agent? If not, who would be the best SME on this matter? I'm sure you understand, since this is a sensitive matter, we need to maintain confidentiality and limit the touch-points within NIH. I'm happy to… **[2020-05-20T13:00:00] Ashley Sanders:** Good afternoon, We are following up on a time-sensitive request for information from the FBI. Please let us know if you are able to accommodate their request or if you can recommend a POC to address the concerns. Thank you, Ashley **[2020-05-20T13:00:00] Ashley Sanders:** let us know if you are able to 2rtain aspects were fficial to sign off on 4/27/20. you understand, since this is a sensitive I'm happy to discuss further if you have ite dn't cates hen it at Good afternoon, We are following up on a time-sensitive request for information from the FBI. Please let us know if you are able to accommodate their request or if you can recommend a POC to address the concerns. Thank you, Ashley **[2020-05-20T13:00:00] Ashley Sanders:** Good afternoon, We are following up on a time-sensitive request for information from the FBI. Please let us know if you are able to accommodate their request or if you can recommend a POC to address the concerns. Thank you, Ashley **[2020-05-20T13:00:00] Ashley Sanders:** Good afternoon, We are following up on a time-sensitive request for information from the FBI. Please let us know if you are able to accommodate their request or if you can recommend a POC to address the concerns. Thank you, Ashley **[2020-05-20T13:00:00] Ashley Sanders:** Good afternoon, We are following up on a time-sensitive request for information from the FBI. Please let us know if you are able to accommodate their request or if you can recommend a POC to address the concerns. Thank you, Ashley **[2020-05-20T13:00:00] Ashley Sanders:** Good afternoon, We are following up on a time-sensitive request for information from the FBI. Please let us know if you are able to accommodate their request or if you can recommend a POC to address the concerns. Thank you, Ashley **[2020-05-20T13:00:00] Ashley Sanders:** Good afternoon, We are following up on a time-sensitive request for information from the FBI. Please let us know if you are able to accommodate their request or if you can recommend a POC to address the concerns. Thank you, Ashley **[2020-05-20T13:00:00] Ashley Sanders:** Good afternoon, We are following up on a time-sensitive request for information from the FBI. Please let us know if you are able to accommodate their request or if you can recommend a POC to address the concerns. Thank you, Ashley **[2020-05-20T13:00:00] Ashley Sanders:** let us know if you are able to 2rtain aspects were fficial to sign off on 4/27/20. you understand, since this is a sensitive I'm happy to discuss further if you have ite dn't cates hen it at Good afternoon, We are following up on a time-sensitive request for information from the FBI. Please let us know if you are able to accommodate their request or if you can recommend a POC to address the concerns. Thank you, Ashley **[2020-05-20T13:00:00] Ashley Sanders:** Good afternoon, We are following up on a time-sensitive request for information from the FBI. Please let us know if you are able to accommodate their request or if you can recommend a POC to address the concerns. Thank you, Ashley **[2020-05-20T13:00:00] Ashley Sanders:** Good afternoon, We are following up on a time-sensitive request for information from the FBI. Please let us know if you are able to accommodate their request or if you can recommend a POC to address the concerns. Thank you, Ashley **[2020-05-20T13:00:00] Ashley Sanders:** Good afternoon, We are following up on a time-sensitive request for information from the FBI. Please let us know if you are able to accommodate their request or if you can recommend a POC to address the concerns. Thank you, Ashley **[2020-05-20T13:00:00] Ashley Sanders:** Good afternoon, We are following up on a time-sensitive request for information from the FBI. Please let us know if you are able to accommodate their request or if you can recommend a POC to address the concerns. Thank you, Ashley **[2020-05-20T13:00:00] Ashley Sanders:** Good afternoon, We are following up on a time-sensitive request for information from the FBI. Please let us know if you are able to accommodate their request or if you can recommend a POC to address the concerns. Thank you, Ashley **[2020-05-21T06:17:00] Emily Linde:** Hi Ashley, let us know if you are able to 2rtain aspects were fficial to sign off on 4/27/20. you understand, since this is a sensitive I'm happy to discuss further if you have The Program Official for this grant, Dr. Stemmy, who is copied on this email, would be the most appropriate POC for these questions. Regards, Emily **[2020-05-21T06:17:00] Emily Linde:** Hi Ashley, The Program Official for this grant, Dr. Stemmy, who is copied on this email, would be the most appropriate POC for these questions. Regards, Emily **[2020-05-21T06:17:00] Emily Linde:** Hi Ashley, let us know if you are able to 2rtain aspects were fficial to sign off on 4/27/20. you understand, since this is a sensitive I'm happy to discuss further if you have The Program Official for this grant, Dr. Stemmy, who is copied on this email, would be the most appropriate POC for these questions. Regards, Emily **[2020-05-21T06:17:00] Emily Linde:** Hi Ashley, The Program Official for this grant, Dr. Stemmy, who is copied on this email, would be the most appropriate POC for these questions. Regards, Emily **[2020-05-21T06:17:00] Emily Linde:** Hi Ashley, The Program Official for this grant, Dr. Stemmy, who is copied on this email, would be the most appropriate POC for these questions. Regards, Emily **[2020-05-21T06:17:00] Emily Linde:** Hi Ashley, The Program Official for this grant, Dr. Stemmy, who is copied on this email, would be the most appropriate POC for these questions. Regards, Emily **[2020-05-21T06:17:00] Emily Linde:** Hi Ashley, let us know if you are able to 2rtain aspects were fficial to sign off on 4/27/20. you understand, since this is a sensitive I'm happy to discuss further if you have The Program Official for this grant, Dr. Stemmy, who is copied on this email, would be the most appropriate POC for these questions. Regards, Emily **[2020-05-21T06:17:00] Emily Linde:** Hi Ashley, The Program Official for this grant, Dr. Stemmy, who is copied on this email, would be the most appropriate POC for these questions. Regards, Emily **[2020-05-21T06:17:00] Emily Linde:** Hi Ashley, let us know if you are able to 2rtain aspects were fficial to sign off on 4/27/20. you understand, since this is a sensitive I'm happy to discuss further if you have The Program Official for this grant, Dr. Stemmy, who is copied on this email, would be the most appropriate POC for these questions. Regards, Emily **[2020-05-21T06:17:00] Emily Linde:** Hi Ashley, The Program Official for this grant, Dr. Stemmy, who is copied on this email, would be the most appropriate POC for these questions. Regards, Emily **[2020-05-21T06:17:00] Emily Linde:** Hi Ashley, The Program Official for this grant, Dr. Stemmy, who is copied on this email, would be the most appropriate POC for these questions. Regards, Emily **[2020-05-21T06:17:00] Emily Linde:** Hi Ashley, The Program Official for this grant, Dr. Stemmy, who is copied on this email, would be the most appropriate POC for these questions. Regards, Emily **[2020-05-21T11:22:00] Erik Stemmy:** Hi Ashley, I would be happy to answer questions related to this award. Would it be best if I just addressed the comments at the end of this email thread? I'll say generally that NIAID has an extensive review process for P3CO (and formerly for GoF) and that all of this work was formally evaluated by the respective committees and determined not to be gain-of-function, nor subject to P3CO oversight. We also continually monitored the progress (until the award was terminated) for evidence of unexpected increases in viral replication. Erik Erik J. Stemmy, Ph.D. Program Officer Respiratory Diseases Branch Division of Microbiology and Infectious Diseases NIAID/NIH/HHS 5601 Fishers Lane, Room 8E18… **[2020-05-21T11:22:00] Erik Stemmy:** Hi Ashley, I would be happy to answer questions related to this award. Would it be best if I just addressed the comments at the end of this email thread? I'll say generally that NIAID has an extensive review process for P3CO (and formerly for GoF) and that all of this work was formally evaluated by the respective committees and determined not to be gain-of-function, nor subject to P3CO oversight. We also continually monitored the progress (until the award was terminated) for evidence of unexpected increases in viral replication. Erik Erik J. Stemmy, Ph.D. Program Officer Respiratory Diseases Branch Division of Microbiology and Infectious Diseases NIAID/NIH/HHS 5601 Fishers Lane, Room 8E18… **[2020-05-21T11:22:00] Erik Stemmy:** Hi Ashley, I would be happy to answer questions related to this award. Would it be best if I just addressed the comments at the end of this email thread? I'll say generally that NIAID has an extensive review process for P3CO (and formerly for GoF) and that all of this work was formally evaluated by the respective committees and determined not to be gain-of-function, nor subject to P3CO oversight. We also continually monitored the progress (until the award was terminated) for evidence of unexpected increases in viral replication. Erik Erik J. Stemmy, Ph.D. Program Officer Respiratory Diseases Branch Division of Microbiology and Infectious Diseases NIAID/NIH/HHS 5601 Fishers Lane, Room 8E18… **[2020-05-21T11:22:00] Erik Stemmy:** Hi Ashley, I would be happy to answer questions related to this award. Would it be best if I just addressed the comments at the end of this email thread? I'll say generally that NIAID has an extensive review process for P3CO (and formerly for GoF) and that all of this work was formally evaluated by the respective committees and determined not to be gain-of-function, nor erminated) for evidence of AID) [--] > let us know if you are able to subject to P3CO oversight. We also continually monitored the progress (until the award was terminated) for evidence of unexpected increases in viral replication. Erik Erik J. Stemmy, Ph.D. Program Officer Respiratory Diseases Branch Division of… **[2020-05-21T11:22:00] Erik Stemmy:** Hi Ashley, I would be happy to answer questions related to this award. Would it be best if I just addressed the comments at the end of this email thread? I'll say generally that NIAID has an extensive review process for P3CO (and formerly for GoF) and that all of this work was formally evaluated by the respective committees and determined not to be gain-of-function, nor subject to P3CO oversight. We also continually monitored the progress (until the award was terminated) for evidence of unexpected increases in viral replication. Erik Erik J. Stemmy, Ph.D. Program Officer Respiratory Diseases Branch Division of Microbiology and Infectious Diseases NIAID/NIH/HHS 5601 Fishers Lane, Room 8E18… **[2020-05-21T11:22:00] Erik Stemmy:** Hi Ashley, I would be happy to answer questions related to this award. Would it be best if I just addressed the comments at the end of this email thread? I'll say generally that NIAID has an extensive review process for P3CO (and formerly for GoF) and that all of this work was formally evaluated by the respective committees and determined not to be gain-of-function, nor subject to P3CO oversight. We also continually monitored the progress (until the award was terminated) for evidence of unexpected increases in viral replication. Erik Erik J. Stemmy, Ph.D. Program Officer Respiratory Diseases Branch Division of Microbiology and Infectious Diseases NIAID/NIH/HHS 5601 Fishers Lane, Room 8E18… **[2020-05-21T11:22:00] Erik Stemmy:** Hi Ashley, I would be happy to answer questions related to this award. Would it be best if I just addressed the comments at the end of this email thread? I'll say generally that NIAID has an extensive review process for P3CO (and formerly for GoF) and that all of this work was formally evaluated by the respective committees and determined not to be gain-of-function, nor subject to P3CO oversight. We also continually monitored the progress (until the award was terminated) for evidence of unexpected increases in viral replication. Erik Erik J. Stemmy, Ph.D. Program Officer Respiratory Diseases Branch Division of Microbiology and Infectious Diseases NIAID/NIH/HHS 5601 Fishers Lane, Room 8E18… **[2020-05-21T11:22:00] Erik Stemmy:** Hi Ashley, I would be happy to answer questions related to this award. Would it be best if I just addressed the comments at the end of this email thread? I'll say generally that NIAID has an extensive review process for P3CO (and formerly for GoF) and that all of this work was formally evaluated by the respective committees and determined not to be gain-of-function, nor subject to P3CO oversight. We also continually monitored the progress (until the award was terminated) for evidence of unexpected increases in viral replication. Erik Erik J. Stemmy, Ph.D. Program Officer Respiratory Diseases Branch Division of Microbiology and Infectious Diseases NIAID/NIH/HHS 5601 Fishers Lane, Room 8E18… **[2020-05-21T11:22:00] Erik Stemmy:** Hi Ashley, I would be happy to answer questions related to this award. Would it be best if I just addressed the comments at the end of this email thread? I'll say generally that NIAID has an extensive review process for P3CO (and formerly for GoF) and that all of this work was formally evaluated by the respective committees and determined not to be gain-of-function, nor subject to P3CO oversight. We also continually monitored the progress (until the award was terminated) for evidence of unexpected increases in viral replication. Erik Erik J. Stemmy, Ph.D. Program Officer Respiratory Diseases Branch Division of Microbiology and Infectious Diseases NIAID/NIH/HHS 5601 Fishers Lane, Room 8E18… **[2020-05-21T11:22:00] Erik Stemmy:** Hi Ashley, I would be happy to answer questions related to this award. Would it be best if I just addressed the comments at the end of this email thread? I'll say generally that NIAID has an extensive review process for P3CO (and formerly for GoF) and that all of this work was formally evaluated by the respective committees and determined not to be gain-of-function, nor erminated) for evidence of AID) [--] > let us know if you are able to subject to P3CO oversight. We also continually monitored the progress (until the award was terminated) for evidence of unexpected increases in viral replication. Erik Erik J. Stemmy, Ph.D. Program Officer Respiratory Diseases Branch Division of… **[2020-05-21T11:22:00] Erik Stemmy:** Hi Ashley, I would be happy to answer questions related to this award. Would it be best if I just addressed the comments at the end of this email thread? I'll say generally that NIAID has an extensive review process for P3CO (and formerly for GoF) and that all of this work was formally evaluated by the respective committees and determined not to be gain-of-function, nor subject to P3CO oversight. We also continually monitored the progress (until the award was terminated) for evidence of unexpected increases in viral replication. Erik Erik J. Stemmy, Ph.D. Program Officer Respiratory Diseases Branch Division of Microbiology and Infectious Diseases NIAID/NIH/HHS 5601 Fishers Lane, Room 8E18… **[2020-05-21T11:22:00] Erik Stemmy:** Hi Ashley, I would be happy to answer questions related to this award. Would it be best if I just addressed the comments at the end of this email thread? I'll say generally that NIAID has an extensive review process for P3CO (and formerly for GoF) and that all of this work was formally evaluated by the respective committees and determined not to be gain-of-function, nor subject to P3CO oversight. We also continually monitored the progress (until the award was terminated) for evidence of unexpected increases in viral replication. Erik Erik J. Stemmy, Ph.D. Program Officer Respiratory Diseases Branch Division of Microbiology and Infectious Diseases NIAID/NIH/HHS 5601 Fishers Lane, Room 8E18… **[2020-05-21T15:04:00] Ashley Sanders:** Hi Erik, Thank you for providing this information. We would like to set up a call with the agent as they may need additional context or have other questions. Would you be available next Tuesday around 11:30AM? I'll set up a conference line for us and send an invite. If that time doesn't work for you, please let me know alternative times you have available. Thank you, Ashley **[2020-05-21T15:04:00] Ashley Sanders:** Hi Erik, Thank you for providing this information. We would like to set up a call with the agent as they may need additional context or have other questions. Would you be available next Tuesday around 11:30AM? I'll set up a conference line for us and send an invite. If that time doesn't work for you, please let me know alternative times you have available. Thank you, Ashley **[2020-05-21T15:04:00] Ashley Sanders:** Hi Erik, Thank you for providing this information. We would like to set up a call with the agent as they may need additional context or have other questions. Would you be available next Tuesday around 11:30AM? I'll set up a conference line for us and send an invite. If that time doesn't work for you, please let me know alternative times you have available. Thank you, Ashley **[2020-05-21T15:04:00] Ashley Sanders:** Hi Erik, Thank you for providing this information. We would like to set up a call with the agent as they may need additional context or have other questions. Would you be available next Tuesday around 11:30AM? I'll set up a conference line for us and send an invite. If that time doesn't work for you, please let me know alternative times you have available. Thank you, Ashley **[2020-05-21T15:04:00] Ashley Sanders:** Hi Erik, Thank you for providing this information. We would like to set up a call with the agent as they may need additional context or have other questions. Would you be available next Tuesday around 11:30AM? I'll set up a conference line for us and send an invite. If that time doesn't work for you, please let me know alternative times you have available. Thank you, Ashley **[2020-05-21T15:04:00] Ashley Sanders:** Hi Erik, Thank you for providing this information. We would like to set up a call with the agent as they may need additional context or have other questions. Would you be available next Tuesday around 11:30AM? I'll set up a conference line for us and send an invite. If that time doesn't work for you, please let me know alternative times you have available. Thank you, Ashley **[2020-05-21T15:04:00] Ashley Sanders:** Hi Erik, Thank you for providing this information. We would like to set up a call with the agent as they may need additional context or have other questions. Would you be available next Tuesday around 11:30AM? I'll set up a conference line for us and send an invite. If that time doesn't work for you, please let me know alternative times you have available. Thank you, Ashley **[2020-05-21T15:04:00] Ashley Sanders:** Hi Erik, Thank you for providing this information. We would like to set up a call with the agent as they may need additional context or have other questions. Would you be available next Tuesday around 11:30AM? I'll set up a conference line for us and send an invite. If that time doesn't work for you, please let me know alternative times you have available. Thank you, Ashley **[2020-05-21T15:04:00] Ashley Sanders:** Hi Erik, Thank you for providing this information. We would like to set up a call with the agent as they may need additional context or have other questions. Would you be available next Tuesday around 11:30AM? I'll set up a conference line for us and send an invite. If that time doesn't work for you, please let me know alternative times you have available. Thank you, Ashley **[2020-05-21T15:04:00] Ashley Sanders:** Hi Erik, Thank you for providing this information. We would like to set up a call with the agent as they may need additional context or have other questions. Would you be available next Tuesday around 11:30AM? I'll set up a conference line for us and send an invite. If that time doesn't work for you, please let me know alternative times you have available. Thank you, Ashley **[2020-05-21T15:04:00] Ashley Sanders:** Hi Erik, Thank you for providing this information. We would like to set up a call with the agent as they may need additional context or have other questions. Would you be available next Tuesday around 11:30AM? I'll set up a conference line for us and send an invite. If that time doesn't work for you, please let me know alternative times you have available. Thank you, Ashley **[2020-05-21T15:04:00] Ashley Sanders:** Hi Erik, Thank you for providing this information. We would like to set up a call with the agent as they may need additional context or have other questions. Would you be available next Tuesday around 11:30AM? I'll set up a conference line for us and send an invite. If that time doesn't work for you, please let me know alternative times you have available. Thank you, Ashley **[2020-05-21T17:50:00] Erik Stemmy:** Hi Ashley, Since we'll only have a short time on Tuesday I thought it might be helpful to provide the agent my responses to the original questions. There may be some misunderstanding of gain-of-function experiments, so hopefully this will clarify some things or at least provide a framework for our discussion next week. Thanks! Erik p.s. I've also pasted the response directly below in case there is an issue adding an attachment to an encrypted message. SF 424 AI110964-06 (received date 11/05/2018) Both SF 424s seem to be describing "gain of function" experiments. On page 192 of SF 424 AI110964-06 (received date 11/05/2018) under P3CO Research, it indicates they are conducting gain of… **[2020-05-21T17:50:00] Erik Stemmy:** Hi Ashley, Since we'll only have a short time on Tuesday I thought it might be helpful to provide the agent my responses to the original questions. There may be some misunderstanding of gain-of-function experiments, so hopefully this will clarify some things or at least provide a framework for our discussion next week. Thanks! Erik p.s. I've also pasted the response directly below in case there is an issue adding an attachment to an encrypted message. SF 424 AI110964-06 (received date 11/05/2018) Both SF 424s seem to be describing "gain of function" experiments. On page 192 of SF 424 AI110964-06 (received date 11/05/2018) under P3CO Research, it indicates they are conducting gain of… **[2020-05-21T17:50:00] Erik Stemmy:** Hi Ashley, Since we'll only have a short time on Tuesday I thought it might be helpful to provide the agent my responses to the original questions. There may be some misunderstanding of gain-of-function experiments, so hopefully this will clarify some things or at least provide a framework for our discussion next week. Thanks! Erik p.s. I've also pasted the response directly below in case there is an issue adding an attachment to an encrypted message. SF 424 AI110964-06 (received date 11/05/2018) Both SF 424s seem to be describing "gain of function" experiments. On page 192 of SF 424 AI110964-06 (received date 11/05/2018) under P3CO Research, it indicates they are conducting gain of… **[2020-05-21T17:50:00] Erik Stemmy:** Hi Ashley, Since we'll only have a short time on Tuesday I thought it might be helpful to provide the agent my responses to the original questions. There may be some misunderstanding of gain-of-function experiments, so hopefully this will clarify some things or at least provide a framework for our discussion next week. Thanks! Erik p.s. I've also pasted the response directly below in case there is an issue adding an attachment to an encrypted message. SF 424 AI110964-06 (received date 11/05/2018) Both SF 424s seem to be describing "gain of function" experiments. On page 192 of SF 424 AI110964-06 (received date 11/05/2018) under P3CO Research, it indicates they are conducting gain of… **[2020-05-21T17:50:00] Erik Stemmy:** Hi Ashley, Since we'll only have a short time on Tuesday I thought it might be helpful to provide the agent my responses to the original questions. There may be some misunderstanding of gain-of-function experiments, so hopefully this will clarify some things or at least provide a framework for our discussion next week. Thanks! Erik p.s. I've also pasted the response directly below in case there is an issue adding an attachment to an encrypted message. SF 424 AI110964-06 (received date 11/05/2018) Both SF 424s seem to be describing "gain of function" experiments. On page 192 of SF 424 AI110964-06 (received date 11/05/2018) under P3CO Research, it indicates they are conducting gain of… **[2020-05-21T17:50:00] Erik Stemmy:** Hi Ashley, Since we'll only have a short time on Tuesday I thought it might be helpful to provide the agent my responses to the original questions. There may be some misunderstanding of gain-of-function experiments, so hopefully this will clarify some things or at least provide a framework for our discussion next week. Thanks! Erik p.s. I've also pasted the response directly below in case there is an issue adding an attachment to an encrypted message. SF 424 AI110964-06 (received date 11/05/2018) Both SF 424s seem to be describing "gain of function" experiments. On page 192 of SF 424 AI110964-06 (received date 11/05/2018) under P3CO Research, it indicates they are conducting gain of… **[2020-05-21T17:50:00] Erik Stemmy:** Hi Ashley, Since we'll only have a short time on Tuesday I thought it might be helpful to provide the agent my responses to the original questions. There may be some misunderstanding of gain-of-function experiments, so hopefully this will clarify some things or at least provide a framework for our discussion next week. Thanks! Erik p.s. I've also pasted the response directly below in case there is an issue adding an attachment to an encrypted message. SF 424 AI110964-06 (received date 11/05/2018) Both SF 424s seem to be describing "gain of function" experiments. On page 192 of SF 424 AI110964-06 (received date 11/05/2018) under P3CO Research, it indicates they are conducting gain of… **[2020-05-21T17:50:00] Erik Stemmy:** Hi Ashley, Since we'll only have a short time on Tuesday I thought it might be helpful to provide the agent my responses to the original questions. There may be some misunderstanding of gain-of-function experiments, so hopefully this will clarify some things or at least provide a framework for our discussion next week. Thanks! Erik p.s. I've also pasted the response directly below in case there is an issue adding an attachment to an encrypted message. SF 424 AI110964-06 (received date 11/05/2018) Both SF 424s seem to be describing "gain of function" experiments. On page 192 of SF 424 AI110964-06 (received date 11/05/2018) under P3CO Research, it indicates they are conducting gain of… **[2020-05-22T11:05:47] Ashley Sanders:** Sanders, Ashley (NIH/OD) [E] @nih.gov) has sent you a prot Read the message Learn about messages protected by Office 365 Message Encryption. Privacy Statement Email encryption powered by Office 365. Learn More Microsoft Corporation, One Microsoft Way, Redmond, WA 98052 164-06 (received date ated 2ring for investigators in this field are to create cDNA I know UNC-Chapel Hill you know where this was he From: "Stemmy, Erik (NIH/NIAID) [E]" To: "Sanders, Ashley (NIH/OD) [E]" < @nih.gov>, "Linde, Emily (NIH/NIAID) [E]" < @mail.nih.gov> Cc: "Shannon, Mike (NIH/OD) [E]" <… **[2020-05-22T11:05:47] Ashley Sanders:** Sanders, Ashley (NIH/OD) [E] @nih.gov) has sent you a prot Read the message Learn about messages protected by Office 365 Message Encryption. Privacy Statement Email encryption powered by Office 365. Learn More Microsoft Corporation, One Microsoft Way, Redmond, WA 98052 164-06 (received date ated 2ring for investigators in this field are to create cDNA I know UNC-Chapel Hill you know where this was he From: "Stemmy, Erik (NIH/NIAID) [E]" To: "Sanders, Ashley (NIH/OD) [E]" < @nih.gov>, "Linde, Emily (NIH/NIAID) [E]" < @mail.nih.gov> Cc: "Shannon, Mike (NIH/OD) [E]" <… **[2020-05-22T15:17:48] Ashley Sanders:** Hi David, In preparation for our call on Tuesday, Erik (cc'd) has provided responses to your initial questions below (also attached). Hope you have a great holiday weekend! Ashley Ashley M. Sanders, MPS Senior Program Investigations Officer NIH, OMA, Division Program Integrity 6011 Executive Blvd. Rockville, Maryland 20852 Office: Cell: @nih.gov SF 424 AI110964-06 (received date 11/05/2018) Both SF 424s seem to be describing "gain of function" experiments. On page 192 of SF 424 AI110964-06 (received date 11/05/2018) under P3CO Research, it indicates they are conducting gain of function of SARSr-CoV. The funding pause on gain-of-function (GoF) experiments was in place from 2014-2017, and… **[2020-05-22T15:17:48] Ashley Sanders:** Hi David, In preparation for our call on Tuesday, Erik (cc'd) has provided responses to your initial questions below (also attached). Hope you have a great holiday weekend! Ashley Ashley M. Sanders, MPS Senior Program Investigations Officer NIH, OMA, Division Program Integrity 6011 Executive Blvd. Rockville, Maryland 20852 Office: Cell: @nih.gov SF 424 AI110964-06 (received date 11/05/2018) Both SF 424s seem to be describing "gain of function" experiments. On page 192 of SF 424 AI110964-06 (received date 11/05/2018) under P3CO Research, it indicates they are conducting gain of function of SARSr-CoV. The funding pause on gain-of-function (GoF) experiments was in place from 2014-2017, and… **[2020-05-22T15:17:48] Ashley Sanders:** Hi David, In preparation for our call on Tuesday, Erik (cc'd) has provided responses to your initial questions below (also attached). Hope you have a great holiday weekend! Ashley Ashley M. Sanders, MPS Senior Program Investigations Officer NIH, OMA, Division Program Integrity 6011 Executive Blvd. Rockville, Maryland 20852 Office: Cell: @nih.gov SF 424 AI110964-06 (received date 11/05/2018) Both SF 424s seem to be describing "gain of function" experiments. On page 192 of SF 424 AI110964-06 (received date 11/05/2018) under P3CO Research, it indicates they are conducting gain of function of SARSr-CoV. The funding pause on gain-of-function (GoF) experiments was in place from 2014-2017, and… **[2020-05-22T15:17:48] Ashley Sanders:** Hi David, In preparation for our call on Tuesday, Erik (cc'd) has provided responses to your initial questions below (also attached). Hope you have a great holiday weekend! Ashley Ashley M. Sanders, MPS Senior Program Investigations Officer NIH, OMA, Division Program Integrity 6011 Executive Blvd. Rockville, Maryland 20852 Office: Cell: @nih.gov SF 424 AI110964-06 (received date 11/05/2018) Both SF 424s seem to be describing "gain of function" experiments. On page 192 of SF 424 AI110964-06 (received date 11/05/2018) under P3CO Research, it indicates they are conducting gain of function of SARSr-CoV. The funding pause on gain-of-function (GoF) experiments was in place from 2014-2017, and… **[2020-09-09T15:15:00] Ashley Sanders:** Good afternoon Emily, I'm following-up on this inquiry - originally the questions circled around the scientific terms of the grant and Erik Stemmy provided the context to the FBI. In a recent discussion with HHS OIG and the FBI, they noted they received information that the below-grant with Ecohealth Alliance was "suspended" or "terminated". I've reviewed QVR and do not see an indication of that action other than the attached "Closeout of Award" email stating the end of the grant was 4/24/20 with a request for the FFR and FRPPR. Was this just a typical end of term closeout, or was it terminated early? If terminated/suspended, the OIG has the following questions: 1. What information did… **[2020-09-09T15:15:00] Ashley Sanders:** Good afternoon Emily, I'm following-up on this inquiry - originally the questions circled around the scientific terms of the grant and Erik Stemmy provided the context to the FBI. In a recent discussion with HHS OIG and the FBI, they noted they received information that the below-grant with Ecohealth Alliance was "suspended" or "terminated". I've reviewed QVR and do not see an indication of that action other than the attached "Closeout of Award" email stating the end of the grant was 4/24/20 with a request for the FFR and FRPPR. Was this just a typical end of term closeout, or was it terminated early? If terminated/suspended, the OIG has the following questions: 1. What information did… **[2020-09-09T15:15:00] Ashley Sanders:** Good afternoon Emily, I'm following-up on this inquiry - originally the questions circled around the scientific terms of the grant and Erik Stemmy provided the context to the FBI. In a recent discussion with HHS OIG and the FBI, they noted they received information that the below-grant with Ecohealth Alliance was "suspended" or "terminated". I've reviewed QVR and do not see an indication of that action other than the attached "Closeout of Award" email stating the end of the grant was 4/24/20 with a request for the FFR and FRPPR. Was this just a typical end of term closeout, or was it terminated early? If terminated/suspended, the OIG has the following questions: 1. What information did… **[2020-09-09T15:15:00] Ashley Sanders:** Good afternoon Emily, I'm following-up on this inquiry - originally the questions circled around the scientific terms of the grant and Erik Stemmy provided the context to the FBI. In a recent discussion with HHS OIG and the FBI, they noted they received information that the below-grant with Ecohealth Alliance was "suspended" or "terminated". I've reviewed QVR and do not see an indication of that action other than the attached "Closeout of Award" email stating the end of the grant was 4/24/20 with a request for the FFR and FRPPR. Was this just a typical end of term closeout, or was it terminated early? If terminated/suspended, the OIG has the following questions: De) a 164-06 (received date… **[2020-09-09T15:15:00] Ashley Sanders:** Good afternoon Emily, I'm following-up on this inquiry - originally the questions circled around the scientific terms of the grant and Erik Stemmy provided the context to the FBI. In a recent discussion with HHS OIG and the FBI, they noted they received information that the below-grant with Ecohealth Alliance was "suspended" or "terminated". I've reviewed QVR and do not see an indication of that action other than the attached "Closeout of Award" email stating the end of the grant was 4/24/20 with a request for the FFR and FRPPR. Was this just a typical end of term closeout, or was it terminated early? If terminated/suspended, the OIG has the following questions: 1. What information did… **[2020-09-09T15:15:00] Ashley Sanders:** Good afternoon Emily, I'm following-up on this inquiry - originally the questions circled around the scientific terms of the grant and Erik Stemmy provided the context to the FBI. In a recent discussion with HHS OIG and the FBI, they noted they received information that the below-grant with Ecohealth Alliance was "suspended" or "terminated". I've reviewed QVR and do not see an indication of that action other than the attached "Closeout of Award" email stating the end of the grant was 4/24/20 with a request for the FFR and FRPPR. Was this just a typical end of term closeout, or was it terminated early? If terminated/suspended, the OIG has the following questions: 1. What information did… **[2020-09-09T15:15:00] Ashley Sanders:** Good afternoon Emily, I'm following-up on this inquiry - originally the questions circled around the scientific terms of the grant and Erik Stemmy provided the context to the FBI. In a recent discussion with HHS OIG and the FBI, they noted they received information that the below-grant with Ecohealth Alliance was "suspended" or "terminated". I've reviewed QVR and do not see an indication of that action other than the attached "Closeout of Award" email stating the end of the grant was 4/24/20 with a request for the FFR and FRPPR. Was this just a typical end of term closeout, or was it terminated early? If terminated/suspended, the OIG has the following questions: 1. What information did… **[2020-09-09T15:15:00] Ashley Sanders:** Good afternoon Emily, I'm following-up on this inquiry - originally the questions circled around the scientific terms of the grant and Erik Stemmy provided the context to the FBI. In a recent discussion with HHS OIG and the FBI, they noted they received information that the below-grant with Ecohealth Alliance was "suspended" or "terminated". I've reviewed QVR and do not see an indication of that action other than the attached "Closeout of Award" email stating the end of the grant was 4/24/20 with a request for the FFR and FRPPR. Was this just a typical end of term closeout, or was it terminated early? If terminated/suspended, the OIG has the following questions: De) a 164-06 (received date… **[2020-09-09T15:26:00] Emily Linde:** Hi Ashley, Questions for that nature on this award should be referred to Dr. Mike Lauer, Deputy Director for Extramural Research. Thanks, Emily **[2020-09-09T15:26:00] Emily Linde:** Hi Ashley, Questions for that nature on this award should be referred to Dr. Mike Lauer, Deputy Director for Extramural Research. Thanks, Emily **[2020-09-09T15:26:00] Emily Linde:** Hi Ashley, Questions for that nature on this award should be referred to Dr. Mike Lauer, Deputy Director for Extramural Research. Thanks, Emily **[2020-09-09T15:26:00] Emily Linde:** Hi Ashley, Questions for that nature on this award should be referred to Dr. Mike Lauer, Deputy Director for Extramural Research. Thanks, Emily **[2020-09-09T15:26:00] Emily Linde:** Hi Ashley, Questions for that nature on this award should be referred to Dr. Mike Lauer, Deputy Director for Extramural Research. Thanks, Emily **[2020-09-09T15:26:00] Emily Linde:** Hi Ashley, Questions for that nature on this award should be referred to Dr. Mike Lauer, Deputy Director for Extramural Research. Thanks, Emily **[2020-09-09T15:26:00] Emily Linde:** Hi Ashley, Questions for that nature on this award should be referred to Dr. Mike Lauer, Deputy Director for Extramural Research. Thanks, Emily **[2020-09-09T15:26:00] Emily Linde:** Hi Ashley, Questions for that nature on this award should be referred to Dr. Mike Lauer, Deputy Director for Extramural Research. Thanks, Emily **[2020-09-09T15:26:00] Emily Linde:** Hi Ashley, Questions for that nature on this award should be referred to Dr. Mike Lauer, Deputy Director for Extramural Research. Thanks, Emily **[2020-09-09T15:26:00] Emily Linde:** Hi Ashley, Questions for that nature on this award should be referred to Dr. Mike Lauer, Deputy Director for Extramural Research. Thanks, Emily **[2020-09-10T10:40:00] Ashley Sanders:** Hi Emily, These questions are specific to whether or not this particular NIAID grant was terminated early or ended as per a usual course of action. I'm not clear as to why I would need to go to the Deputy Director of NIH for OER for a response to a question on decisions and grant determinations made by NIAID. OMA properly and routinely seeks and receives information from IC's on grants and grant activity in support of audits and investigations, in accordance with Manual Chapter 1754 and 1752, as we are responsible to fully coordinate responses to OIG/FBI/DOJ etc. to support ongoing investigations. I must ensure our response is from the most relevant and accurate source of information, and… **[2020-09-10T10:40:00] Ashley Sanders:** /0)) cE) as /0)) (] as Hi Emily, These questions are specific to whether or not this particular NIAID grant was terminated early or ended as per a usual course of action. I'm not clear as to why I would need to go to the Deputy Director of NIH for OER for a response to a question on decisions and grant determinations made by NIAID. OMA properly and routinely seeks and receives information from IC's on grants and grant activity in support of audits and investigations, in accordance with Manual Chapter 1754 and 1752, as we are responsible to fully coordinate responses to OIG/FBI/DOJ etc. to support ongoing investigations. I must ensure our response is from the most relevant and accurate… **[2020-09-10T10:40:00] Ashley Sanders:** Hi Emily, These questions are specific to whether or not this particular NIAID grant was terminated early or ended as per a usual course of action. I'm not clear as to why I would need to go to the Deputy Director of NIH for OER for a response to a question on decisions and grant determinations made by NIAID. OMA properly and routinely seeks and receives information from IC's on grants and grant activity in support of audits and investigations, in accordance with Manual Chapter 1754 and 1752, as we are responsible to fully coordinate responses to OIG/FBI/DOJ etc. to support ongoing investigations. I must ensure our response is from the most relevant and accurate source of information, and… **[2020-09-10T10:40:00] Ashley Sanders:** Hi Emily, These questions are specific to whether or not this particular NIAID grant was terminated early or ended as per a usual course of action. I'm not clear as to why I would need to go to the Deputy Director of NIH for OER for a response to a question on decisions and grant determinations made by NIAID. OMA properly and routinely seeks and receives information from IC's on grants and grant activity in support of audits and investigations, in accordance with Manual Chapter 1754 and 1752, as we are responsible to fully coordinate responses to OIG/FBI/DOJ etc. to support ongoing investigations. I must ensure our response is from the most relevant and accurate source of information, and… **[2020-09-10T10:40:00] Ashley Sanders:** /0)) cE) as /0)) (] as Hi Emily, These questions are specific to whether or not this particular NIAID grant was terminated early or ended as per a usual course of action. I'm not clear as to why I would need to go to the Deputy Director of NIH for OER for a response to a question on decisions and grant determinations made by NIAID. OMA properly and routinely seeks and receives information from IC's on grants and grant activity in support of audits and investigations, in accordance with Manual Chapter 1754 and 1752, as we are responsible to fully coordinate responses to OIG/FBI/DOJ etc. to support ongoing investigations. I must ensure our response is from the most relevant and accurate… **[2020-09-10T10:40:00] Ashley Sanders:** Hi Emily, These questions are specific to whether or not this particular NIAID grant was terminated early or ended as per a usual course of action. I'm not clear as to why I would need to go to the Deputy Director of NIH for OER for a response to a question on decisions and grant determinations made by NIAID. OMA properly and routinely seeks and receives information from IC's on grants and grant activity in support of audits and investigations, in accordance with Manual Chapter 1754 and 1752, as we are responsible to fully coordinate responses to OIG/FBI/DOJ etc. to support ongoing investigations. I must ensure our response is from the most relevant and accurate source of information, and… **[2020-09-10T11:40:00] Emily Linde:** Hi Ashley, For this award the most relevant and accurate source of information is Dr. Mike Lauer, Deputy Director for Extramural Research. Thanks, Emily **[2020-09-10T11:40:00] Emily Linde:** Hi Ashley, For this award the most relevant and accurate source of information is Dr. Mike Lauer, Deputy Director for Extramural Research. Thanks, Emily **[2020-09-10T11:40:00] Emily Linde:** Hi Ashley, For this award the most relevant and accurate source of information is Dr. Mike Lauer, Deputy Director for Extramural Research. Thanks, Emily /0)) cE as /0)) (] as 1/0) cE] as **[2020-09-10T11:40:00] Emily Linde:** Hi Ashley, For this award the most relevant and accurate source of information is Dr. Mike Lauer, Deputy Director for Extramural Research. Thanks, Emily **[2020-09-10T11:40:00] Emily Linde:** Hi Ashley, For this award the most relevant and accurate source of information is Dr. Mike Lauer, Deputy Director for Extramural Research. Thanks, Emily **[2020-09-10T11:40:00] Emily Linde:** Hi Ashley, For this award the most relevant and accurate source of information is Dr. Mike Lauer, Deputy Director for Extramural Research. Thanks, Emily /0)) cE as /0)) (] as 1/0) cE] as **[2020-09-10T11:44:00] Emily Linde:** Good morning, I wanted to alert you to this request. I referred them to Mike as we have discussed and just sent the following response to their latest inquiry and will let you know if I hear more. Thanks, Emily **[2020-09-10T11:44:00] Emily Linde:** Good morning, I wanted to alert you to this request. I referred them to Mike as we have discussed and just sent the following response to their latest inquiry and will let you know if I hear more. Thanks, Emily **[2020-09-10T11:44:00] Emily Linde:** Good morning, I wanted to alert you to this request. I referred them to Mike as we have discussed and just sent the following response to their latest inquiry and will let you know if I hear more. Thanks, Emily **[2020-09-10T11:44:00] Emily Linde:** Good morning, I wanted to alert you to this request. I referred them to Mike as we have discussed and just sent the following response to their latest inquiry and will let you know if I hear more. Thanks, Emily **[2020-09-10T11:44:00] Emily Linde:** Good morning, I wanted to alert you to this request. I referred them to Mike as we have discussed and just sent the following response to their latest inquiry and will let you know if I hear more. Thanks, Emily **[2020-09-10T11:44:00] Emily Linde:** Good morning, I wanted to alert you to this request. I referred them to Mike as we have discussed and just sent the following response to their latest inquiry and will let you know if I hear more. Thanks, Emily **[2020-09-10T11:44:00] Emily Linde:** Good morning, I wanted to alert you to this request. I referred them to Mike as we have discussed and just sent the following response to their latest inquiry and will let you know if I hear more. Thanks, Emily **[2020-09-10T11:44:00] Emily Linde:** Good morning, I wanted to alert you to this request. I referred them to Mike as we have discussed and just sent the following response to their latest inquiry and will let you know if I hear more. Thanks, Emily **[2020-09-10T12:43:00] Michelle G Bulls:** Hi Mike, See way down below where OMA asks for information for the OIG and FBI regarding Eco Health Alliance. Emily referred them back to you, based on the nature of their questions. This is a sticky one--and from the beginning, NIAID were told to refer these detailed questions to you given the situation. Is it okay for us to provide her with a response to send that is accurate so that OMA does not have to translate? Or would you like for her to just respond and without context, that will be tricky for OMA and will cause more questions. Let me know... Michelle **[2020-09-10T12:43:00] Michelle G Bulls:** Hi Mike, See way down below where OMA asks for information for the OIG and FBI regarding Eco Health Alliance. Emily referred them back to you, based on the nature of their questions. This is a sticky one--and from the beginning, NIAID were told to refer these detailed questions to you given the situation. Is it okay for us to provide her with a response to send that is accurate so that OMA does not have to translate? Or would you like for her to just respond and without context, that will be tricky for OMA and will cause more questions. Let me know... Michelle **[2020-09-10T12:43:00] Michelle G Bulls:** Hi Mike, See way down below where OMA asks for information for the OIG and FBI regarding Eco Health Alliance. Emily referred them back to you, based on the nature of their questions. This is a sticky one--and from the beginning, NIAID were told to refer these detailed questions to you given the situation. Is it okay for us to provide her with a response to send that is accurate so that OMA does not have to translate? Or would you like for her to just respond and without context, that will be tricky for OMA and will cause more questions. Let me know... Michelle **[2020-09-10T12:43:00] Michelle G Bulls:** Hi Mike, See way down below where OMA asks for information for the OIG and FBI regarding Eco Health Alliance. Emily referred them back to you, based on the nature of their questions. This is a sticky one--and from the beginning, NIAID were told to refer these detailed questions to you given the situation. Is it okay for us to provide her with a response to send that is accurate so that OMA does not have to translate? Or would you like for her to just respond and without context, that will be tricky for OMA and will cause more questions. Let me know... Michelle **[2020-09-10T12:43:00] Michelle G Bulls:** Hi Mike, See way down below where OMA asks for information for the OIG and FBI regarding Eco Health Alliance. Emily referred them back to you, based on the nature of their questions. This is a sticky one--and from the beginning, NIAID were told to refer these detailed questions to you given the situation. Is it okay for us to provide her with a response to send that is accurate so that OMA does not have to translate? Or would you like for her to just respond and without context, that will be tricky for OMA and will cause more questions. Let me know... Michelle **[2020-09-10T12:43:00] Michelle G Bulls:** Hi Mike, See way down below where OMA asks for information for the OIG and FBI regarding Eco Health Alliance. Emily referred them back to you, based on the nature of their questions. This is a sticky one--and from the beginning, NIAID were told to refer these detailed questions to you given the situation. Is it okay for us to provide her with a response to send that is accurate so that OMA does not have to translate? Or would you like for her to just respond and without context, that will be tricky for OMA and will cause more questions. Let me know... Michelle **[2020-09-10T12:43:04] Michelle G Bulls:** Hi Mike, See way down below where OMA asks for information for the OIG and FBI regarding Eco Health Alliance. Emily referred them back to you, based on the nature of their questions. This is a sticky one--and from the beginning, NIAID were told to refer these detailed questions to you given the situation. Is it okay for us to provide her with a response to send that is accurate so that OMA does not have to translate? Or would you like for her to just respond and without context, that will be tricky for OMA and will cause more questions. Let me know... Michelle **[2020-09-10T12:43:04] Michelle G Bulls:** Hi Mike, See way down below where OMA asks for information for the OIG and FBI regarding Eco Health Alliance. Emily referred them back to you, based on the nature of their questions. This is a sticky one--and from the beginning, NIAID were told to refer these detailed questions to you given the situation. Is it okay for us to provide her with a response to send that is accurate so that OMA does not have to translate? Or would you like for her to just respond and without context, that will be tricky for OMA and will cause more questions. Let me know... Michelle **[2020-09-11T04:36:36] Michael Lauer:** Thanks Michelle - I agree with your plan we should handle this. We might also want to include OGC / Anna Jacobs in our conversations with OMA. Best, Mike Note: This conversation is restricted, so you might not be able to cut or copy from it. See the information above the To line for more details. Also, while the conversation is restricted, the conversation owner can send the message to other people. **[2020-09-11T04:36:36] Michael Lauer:** Thanks Michelle - I agree with your plan we should handle this. We might also want to include OGC / Anna Jacobs in our conversations with OMA. Best, Mike Note: This conversation is restricted, so you might not be able to cut or copy from it. See the information above the To line for more details. Also, while the conversation is restricted, the conversation owner can send the message to other people. **[2020-09-11T04:37:00] Michael Lauer:** Thanks Michelle - I agree with your plan we should handle this. We might also want to include OGC / Anna Jacobs in our conversations with OMA. Best, Mike Note: This conversation is restricted, so you might not be able to cut or copy from it. See the information above the To line for more details. Also, while the conversation is restricted, the conversation owner can send the message to other people. 00) (e)" i > .0964-06 (E] > 1d just sent the following response to /0) ct is /o) ck is **[2020-09-11T04:37:00] Michael Lauer:** We might also want to include OGC / Anna Jacobs in our 50) (e)" > .0964-06 (E] > 1d just sent the following response to /o) ck is Thanks Michelle - I agree with your plan we should handle this. We might also want to include OGC / Anna Jacobs in our conversations with OMA. Best, Mike Note: This conversation is restricted, so you might not be able to cut or copy from it. See the information above the To line for more details. Also, while the conversation is restricted, the conversation owner can send the message to other people. **[2020-09-11T04:37:00] Michael Lauer:** Thanks Michelle - I agree with your plan we should handle this. We might also want to include OGC / Anna Jacobs in our conversations with OMA. Best, Mike Note: This conversation is restricted, so you might not be able to cut or copy from it. See the information above the To line for more details. Also, while the conversation is restricted, the conversation owner can send the message to other people. 00) (e)" i > .0964-06 (E] > 1d just sent the following response to /0) ct is /o) ck is **[2020-09-11T04:37:00] Michael Lauer:** We might also want to include OGC / Anna Jacobs in our 50) (e)" > .0964-06 (E] > 1d just sent the following response to /o) ck is Thanks Michelle - I agree with your plan we should handle this. We might also want to include OGC / Anna Jacobs in our conversations with OMA. Best, Mike Note: This conversation is restricted, so you might not be able to cut or copy from it. See the information above the To line for more details. Also, while the conversation is restricted, the conversation owner can send the message to other people. **[2020-09-11T09:23:00] Michelle G Bulls:** Mike, Just to provide you with an update on this one. Mike Shannon went to NIAIDs Deputy Director last evening to note that Emily was being "non-responsive" so the issue would be escalated. Emily said that as soon as the Deputy Director figured out which grant was involved, they knew that Emily had acted appropriately, and that OMA should be trusting her professional judgement. The Deputy Director is meeting with Mike Shannon today to discuss. You were not included in the emails from Mike Shannon at any point, not even as a FYI. Really happy that NIAID leadership supported Emily--huge in this case. Just want you know what's going on in this space and the fact that Mike is meeting w/the… **[2020-09-11T09:23:00] Michelle G Bulls:** Mike, Just to provide you with an update on this one. Mike Shannon went to NIAIDs Deputy Director last evening to note that Emily was being "non-responsive" so the issue would be escalated. Emily said that as soon as the Deputy Director figured out which grant was involved, they knew that Emily had acted appropriately, and that OMA should be trusting her professional judgement. The Deputy Director is meeting with Mike Shannon today to discuss. You were not included in the emails from Mike Shannon at any point, not even as a FYI. Really happy that NIAID leadership supported Emily--huge in this case. Just want you know what's going on in this space and the fact that Mike is meeting w/the… **[2020-09-11T09:23:00] Michelle G Bulls:** Mike, Just to provide you with an update on this one. Mike Shannon went to NIAIDs Deputy Director last evening to note that Emily was being "non-responsive" so the issue would be escalated. Emily said that as soon as the Deputy Director figured out which grant was involved, they knew that Emily had acted appropriately, and that OMA should be trusting her professional judgement. The Deputy Director is meeting with Mike Shannon today to discuss. You were not included in the emails from Mike Shannon at any point, not even as a FYI. Really happy that NIAID leadership supported Emily--huge in this case. Just want you know what's going on in this space and the fact that Mike is meeting w/the… **[2020-09-11T09:23:00] Michelle G Bulls:** Mike, Just to provide you with an update on this one. Mike Shannon went to NIAIDs Deputy Director last evening to note that Emily was being "non-responsive" so the issue would be escalated. Emily said that as soon as the Deputy Director figured out which grant was involved, they knew that Emily had acted appropriately, and that OMA should be trusting her professional judgement. The Deputy Director is meeting with Mike Shannon today to discuss. You were not included in the emails from Mike Shannon at any point, not even as a FYI. Really happy that NIAID leadership supported Emily--huge in this case. Just want you know what's going on in this space and the fact that Mike is meeting w/the… **[2020-09-13T13:23:53] Michael Lauer:** Thanks Michelle for the update and good to hear that NIAID backed up Emily. I'll be talking with Ashley Sanders (OMA) from 8:30 AM to 9:00 to tell her the story behind the case. Best, Mike Note: This conversation is restricted, so you might not be able to cut or copy from it. See the information above the To line for more details. Also, while the conversation is restricted, the conversation owner can send the message to other people. **[2020-09-13T13:23:53] Michael Lauer:** Thanks Michelle for the update and good to hear that NIAID backed up Emily. I'll be talking with Ashley Sanders (OMA) from 8:30 AM to 9:00 to tell her the story behind the case. Best, Mike Note: This conversation is restricted, so you might not be able to cut or copy from it. See the information above the To line for more details. Also, while the conversation is restricted, the conversation owner can send the message to other people. **[2020-09-13T13:24:00] Michael Lauer:** Thanks Michelle for the update and good to hear that NIAID backed up Emily. I'll be talking with Ashley Sanders (OMA) from 8:30 AM to 9:00 to tell her the story behind the case. Best, Mike Note: This conversation is restricted, so you might not be able to cut or copy from it. See the information above the To line for more details. Also, while the conversation is restricted, the conversation owner can send the message to other people. **[2020-09-13T13:24:00] Michael Lauer:** Thanks Michelle for the update and good to hear that NIAID backed up Emily. I'll be talking with Ashley Sanders (OMA) from 8:30 AM to 9:00 to tell her the story behind the case. Best, Mike Note: This conversation is restricted, so you might not be able to cut or copy from it. See the information above the To line for more details. Also, while the conversation is restricted, the conversation owner can send the message to other people. **[2020-09-14T16:42:00] Michelle G Bulls:** Perfect! Thanks so much, Mike. **[2020-09-14T16:42:00] Michelle G Bulls:** Perfect! Thanks so much, Mike.